Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU medical devices directive

This article was originally published in The Gray Sheet

Executive Summary

Review of 93/42/EEC is on track for finalization before the European summer recess. Released June 5, the 1report of the Medical Devices Expert Group on the functioning of the MDD is a follow-up to the European Commission's report on the expert group's most recent draft in March (2"The Gray Sheet" March 18, 2002, p. 8). According to the commission, there is a strong and general consensus between member states and industry that the MDD has performed well, but some improvements could be made for high-risk products and clinical investigations...

You may also be interested in...



EU Medical Devices Directive Review Invites Reclassification Requests

The European Commission is encouraging member states to use Article 13 of the Medical Devices Directive to submit requests for reclassification, rather than reforming the directive itself

Fujifilm Demonstrates Health Specialism With European HealthTech Spinout

From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics. 

Financing Quarterly Statistics, Q1 2024

During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016764

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel